Endpoints News 5. Feb. 2026 Telehealth provider Hims goes after Novo's weight loss pill with compounded version
Endpoints News 4. Feb. 2026 Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
FierceBiotech 28. Jan. 2026 With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera
BioPharma Dive 23. Jan. 2026 Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal
PLoS Biology 23. Jan. 2026 Dynamic auxin maxima regulate male-to-hermaphrodite conversion and de novo meristem formation in the fern <i>Ceratopteris</i> gametophytes
FierceBiotech 21. Jan. 2026 Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat
Endpoints News 15. Jan. 2026 FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory
FierceBiotech 15. Jan. 2026 Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs
Endpoints News 15. Jan. 2026 Novo Nordisk Foundation to inject $850M+ into BioInnovation Institute through 2035
Endpoints News 12. Jan. 2026 #JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
Cell 25. Nov. 2025 A <em>de novo</em>-originated gene drives rose scent diversification #Junzhong Shang #Yaqi Sui
Cell 25. Nov. 2025 <em>De novo</em> design of a peptide modulator to reverse sodium channel dysfunction linked to cardiac arrhythmias and epilepsy #Ryan Mahling #Bence Hegyi